PhD studentships in immune tolerance at The Max Planck Institute for Immunobiology in Freiburg, Germany

The Max Planck Institute for Immunobiology in Freiburg, Germany,

invites applications for PhD studentships in immune tolerance
available in the newly established research group of Dr. Ana Izcue.

Starting date is October 1, 2009. Earlier/Later dates could be considered.
The Position is for an initial two-year appointment with the possibility of extension.
The group studies the molecular mechanisms regulating specific tolerance
in the immune system both in mouse models and in humans (for further
information, see Izcue et al., Immunity 28, 559, 2008; Izcue, Coombes and
Powrie, Ann. Rev. Immunol. 27, in press, 2009). The group belongs to the
Department of Developmental Immunology at the Max Planck Institute
(http://www.immunbio.mpg.de) and it is also part of the Centre of Chronic
Immunodeficiencies at the University of Freiburg, providing unique
opportunities to interact with basic and clinical scientists.
The PhD students will work on the role of epithelial cells in the induction
of T cell tolerance in the intestine, especially the pathways leading to the
generation of Foxp3+ regulatory T cells.

We seek motivated and ambitious individuals and provide a well-equipped,
world-class research environment. Students should have a Diploma/Master
degree or equivalent; experience in molecular or cell immunology and in
vivo models would be an advantage.

The salary is commensurate with the guidelines for fellowships of the Max-
Planck-Society or the regulations of the TVöD. The MPI of Immunobiology
is an international research institute with English as the working language.
A childcare facility is attached to the Institute. Women are especially encouraged
to apply; handicapped applicants with equal qualifications will be given
preferential treatment.

Informal enquiries should be directed to
Dr. Ana Izcue (email: ana.izcue@path.ox.ac.uk).

Applications giving relevant information about professional
qualification, motivation, and names of referees and indicating reference
number 020309 should be sent directly via email to weigold@immunbio.mpg.de
or to the Personnel Department, Max-Planck-Institute of Immunobiology,
Stübeweg 51, 79108 Freiburg, Germany.
Applications will be accepted until May 31, 2009.
MAX-PLANCK-GESELLSCHAFT

Link PDF